Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

4Q Pharma Results Preview: J&J, Novartis, Bristol, Celgene, Biogen

Jan 20 2017

• By Scrip Team

Related Content

Game Changer: Merck's Stealth Keytruda-Chemo Filing Stirs NSCLC Market Dynamics

Jan 11 2017

Pharma Strategizes On Drug Pricing On Day One Of J.P. Morgan

Jan 10 2017

Novartis Chief: Good Things Come To Those Who Wait

Oct 26 2016

'Total Disaster' In First-Line Lung Cancer For BMS's Opdivo

Oct 10 2016

Was Sanofi’s Offer One That Actelion Could Refuse? J&J Back At Bargaining Table

Dec 22 2016

Biogen/Ionis’s Spinraza Approved; Second Antisense Drug For Neurodegeneration In 2016

Dec 28 2016

Actelion Could Succumb To Big Pharma's Charms

Nov 28 2016

Celgene diversifies with $7.2bn Receptos buy

Jul 15 2015

Related Companies

Johnson & Johnson

Actelion Pharmaceuticals Ltd.

Sanofi

Novartis AG

Novartis AG

GSK plc

Bristol Myers Squibb Company

Merck & Co., Inc.

Bristol Myers Squibb Company

Receptos, Inc.

Genetix Biotherapeutics

Bristol Myers Squibb Company

Agios Pharmaceuticals, Inc.

Biogen, Inc.

Additional Topics

Sales & Earnings Companies Strategy Commercial BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window